Dina H. Abushanab

553 St Kilda Road
Melbourne, VIC 3004, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 67 publications

What Does "Success" Mean in the Cost-Effectiveness of Fetal Fibronectin Testing? [Response to Letter].

What Does "Success" Mean in the Cost-Effectiveness of Fetal Fibronectin Testing? [Response to Letter].

Journal: ClinicoEconomics and outcomes research : CEOR

Published: August 21, 2026

Global Burden of Elevated LDL-C: Findings From the Global Burden of Disease Study 2023.

Global Burden of Elevated LDL-C: Findings From the Global Burden of Disease Study 2023.

Journal: JAMA

Published: July 29, 2026

Financial Toxicity: Inequities and Impact on Cardiovascular Disease.

Financial Toxicity: Inequities and Impact on Cardiovascular Disease.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: June 25, 2026

Medicine Requirements and Budget Implication for Pediatric Acute Lymphoblastic Leukemia in Indonesia: A Morbidity-Based Approach.

Medicine Requirements and Budget Implication for Pediatric Acute Lymphoblastic Leukemia in Indonesia: A Morbidity-Based Approach.

Journal: Risk management and healthcare policy

Published: April 29, 2026

Cost-Effectiveness of Fetal Fibronectin Testing in Women at Risk for Preterm Birth: A Retrospective Cohort Study.

Cost-Effectiveness of Fetal Fibronectin Testing in Women at Risk for Preterm Birth: A Retrospective Cohort Study.

Journal: ClinicoEconomics and outcomes research : CEOR

Published: March 25, 2026

Activity-Based Costing of COVID-19 RT-PCR Testing in Public Laboratories in Indonesia: Evidence for Tariff Setting.

Activity-Based Costing of COVID-19 RT-PCR Testing in Public Laboratories in Indonesia: Evidence for Tariff Setting.

Journal: ClinicoEconomics and outcomes research : CEOR

Published: February 05, 2026

Prescribing trends of cardioprotective medications among patients with diabetes and ASCVD in primary care setting in Qatar.

Prescribing trends of cardioprotective medications among patients with diabetes and ASCVD in primary care setting in Qatar.

Journal: Journal of pharmaceutical policy and practice

Published: December 11, 2025

Extent and Mitigation of Financial Toxicity of Immune Checkpoint Inhibitors for the Treatment of Advanced Hepatocellular Carcinoma.

Extent and Mitigation of Financial Toxicity of Immune Checkpoint Inhibitors for the Treatment of Advanced Hepatocellular Carcinoma.

Journal: Cancer control : journal of the Moffitt Cancer Center

Published: November 26, 2025

The next decade of cardiovascular disease burden in Qatar, a gulf cooperation council country: Projections from 2024 to 2033.

The next decade of cardiovascular disease burden in Qatar, a gulf cooperation council country: Projections from 2024 to 2033.

Journal: Current problems in cardiology

Published: October 11, 2025

The Cost of Resource Use Relative to the Development of the Antimicrobial Stewardship Program in a Tertiary Cancer Setting in Qatar.

The Cost of Resource Use Relative to the Development of the Antimicrobial Stewardship Program in a Tertiary Cancer Setting in Qatar.

Journal: Antibiotics (Basel, Switzerland)

Published: September 19, 2025

Quality-of-life measures in pharmacogenomic studies: a systematic review.

Quality-of-life measures in pharmacogenomic studies: a systematic review.

Journal: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation

Published: July 10, 2025

Scoping Review of Productivity-Adjusted Life Years (PALYs): Methods, Applications and Policy Implications.

Scoping Review of Productivity-Adjusted Life Years (PALYs): Methods, Applications and Policy Implications.

Journal: PharmacoEconomics

Published: June 23, 2025

Showing 1-12 of 67

Last Updated: 09/26/2026